A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time
Clinical trial NCT01614665 · COMPLETED
Trial details
- NCT number
- NCT01614665
- Sponsor
- Astellas Pharma Europe Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-03
- Primary completion
- 2021-04-21
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.